by Jordana Choucair | Jun 24, 2022 | Life Sciences
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) unanimously endorsed Moderna’s vaccine for use in those between the ages of 6 and 17. Previously, the only COVID-19 vaccine authorized for use in children between...
by Jordana Choucair | Jun 24, 2022 | Life Sciences
New data found that COVID-19 vaccines prevented an estimated 20 million deaths in the first year after they were made available, mostly in wealthier countries. Researchers estimated that more than 7 million lives were saved in countries covered by the vaccine-sharing...
by Jordana Choucair | Jun 23, 2022 | Life Sciences
The Food and Drug Administration (FDA) is set to take Juul e-cigarette products off store shelves. The FDA plans to deny Juul a marketing order for its menthol and tobacco-flavored products after a two-year review that weighed the products’ benefits for adult...
by Jordana Choucair | Jun 22, 2022 | Life Sciences
The Food and Drug Administration (FDA) is set to propose limits on the levels of nicotine tobacco companies can place in traditional cigarettes. The plan, which follows the agency’s proposed ban on menthol-flavored cigarettes, is an attempt to help prevent young...
by Jordana Choucair | Jun 21, 2022 | Life Sciences
The Centers for Disease Control and Prevention (CDC) recommended Saturday that children as young as 6 months old receive COVID-19 vaccines developed by Pfizer-BioNTech and Moderna. The move follows unanimous votes earlier from the CDC’s Advisory Committee on...
by Jordana Choucair | Jun 21, 2022 | Life Sciences
fizer agreed to invest $95 million to buy an 8.1 percent percent stake in French vaccines company Valneva. Pfizer and Valneva previously partnered to create a joint Lyme disease program, which is developing a Lyme disease vaccine candidate called VLA15. Valneva is...
Recent Comments